openPR Logo
Press release

Bellus All Natural Labs Wins Prestigious 2024 Corporate Excellence Magazine Award

09-05-2024 08:44 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Getnews

/ PR Agency: Comms Factory
Bellus All Natural Labs Wins Prestigious 2024 Corporate

Corporate Vision Magazine recognizes Bellus for product formulation and private label cosmetic achievements
POMPTON PLAINS, NJ - Sep 5, 2024 - Bellus All Natural Labs, the U.S. leader in private label and custom health and beauty (H&B) formulations, today announced it has received the 2024 Corporate Excellence Award from Corporate Vision Magazine for "Best Private Label Skincare and Custom Formulation Company." Bellus is a formulation services contract manufacturer of private label skincare, private label haircare and unique pet products.

Every year, Corporate Vision Magazine acknowledges exceptional small businesses that stand out in their respective categories. They recognized Bellus for its significant impact in the health and beauty space through innovation and achievements in the small business community. According to the magazine, "...a business that is dedicated to its craft is our front cover feature, Bellus Labs, which we are thrilled to have named 'Best Private Label Skincare and Custom Formulation Company 2024 - USA.'"

The magazine added, "Founded and led by husband-and-wife team, Michael and Kristina Cimo, Bellus Labs has proven itself to be a true force to be reckoned with in the skincare industry. We discover how the company has achieved such outstanding success."

Bellus is renowned for producing bespoke, private label skincare products. Their tailor-made skincare formulations and personalized solutions are formulated to the exact specifications and unique skincare product vision of its clients. The company has also been recognized by Vogue, InStyle, GQ, Glamour and Elle.

According to Sienna Valent, Production Manager at Bellus, "Winning this Global Award has significantly enhanced our visibility, enabling us to offer clients the finest formulations available. Our Private Label Luxe Line provides an unparalleled luxury experience, granting clients access to the next generation of premium products. This recognition and our commitment to excellence ensure that our clients receive exceptional quality and innovative solutions that elevate their brand and meet their highest expectations."

She added, "The time, research, and creativity invested in developing our Luxe formulations are set to transform the private label industry forever. We've meticulously crafted these products to redefine luxury, setting a new standard that will elevate our clients' brands and offer them an unparalleled experience."

Kelly McMinn, R&D Manager at Bellus, remarked, "Years of in-depth research and invaluable client feedback have shown us a clear need for a Luxe private label line that stands out in a crowded market. We're thrilled to introduce a collection that not only meets this demand but exceeds expectations, providing our clients with a truly distinctive and luxurious experience that sets them apart from the rest. This is a game-changer for the industry, and we're excited to see the impact it will have."

For more information visit https://www.sbellus.com/
Media Contact
Company Name: Bellus All Natural Labs
Contact Person: Media Relations
Email: Send Email [http://www.universalpressrelease.com/?pr=bellus-all-natural-labs-wins-prestigious-2024-corporate-excellence-magazine-award]
Country: United States
Website: https://www.sbellus.com/



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bellus All Natural Labs Wins Prestigious 2024 Corporate Excellence Magazine Award here

News-ID: 3647041 • Views:

More Releases from Getnews

Dr Jeffrey Mathews Calls for Greater Awareness of Oral-Systemic Health Connection
Dr Jeffrey Mathews Calls for Greater Awareness of Oral-Systemic Health Connectio …
Feature interview highlights the growing link between oral health, confidence, and long-term wellbeing Dr Jeffrey Mathews, DDS, a leading cosmetic and family dentist based in Goodlettsville, Tennessee, is using the release of his new in-depth interview, In Conversation with Dr Jeffrey Mathews: The Future of Dentistry and Beyond, to raise awareness of the strong connection between oral health and overall systemic health. Drawing from his 15 years of clinical experience, Dr Mathews
Capodagli Property Company Unveils Plans for Upcoming Leasing at Meridia Bound Brook 300
Capodagli Property Company Unveils Plans for Upcoming Leasing at Meridia Bound B …
Image: https://www.globalnewslines.com/uploads/2025/12/1764950075.jpg Bound Brook 300 is a six-story, mixed-use residential development that will redefine urban living in Bound Brook. Linden, New Jersey - December 5, 2025 - The project will feature 60 thoughtfully designed residential units [http://capodagli.com/] plus one management unit, offering modern and comfortable living spaces for a diverse community. Residents will also enjoy convenient amenities, including 12 cage storage units, and 35 bike parking spaces. Meridia Bound Brook 300 will include
IABDM Announces 2026 Annual Conference:
IABDM Announces 2026 Annual Conference: "Biohacking in Dentistry" With Exclusive …
Apex, NC - The International Academy of Biological Dentistry and Medicine (IABDM) has announced its 2026 Annual Conference: Biohacking in Dentistry, a landmark event exploring how emerging biohacking tools, advanced diagnostics, and integrative health strategies are transforming modern biological dentistry. The conference will feature expert-led keynotes, hands-on sessions, and an Exhibitor Expo showcasing the latest technologies and holistic innovations. Attendees will also benefit from exclusive early bird pricing now available
Former LivePerson CEO Launches KID Registered , a Safe Creative AI Device Amid Alarming AI Toy Safety Findings.
Former LivePerson CEO Launches KID Registered , a Safe Creative AI Device Amid A …
Image: https://www.globalnewslines.com/uploads/2025/12/1764947497.jpg LOS ALTOS, Calif. - Dec 5, 2025 - KID Company [https://www.kidco.ai/] today announced the launch of KID Registered , a creative AI device built specifically for children ages 4 to 12. With no ads, no browsing, and no scrolling, KID offers families a safer alternative to screens optimized for attention. Parents maintain clear visibility and control through a transparent parent app -without surveillance. KID's design philosophy extends beyond software to

All 5 Releases


More Releases for Bellus

U.S. Microneedling Market New Product Development & Latest Trends | Revance Ther …
"The U.S. Microneedling Market Size is projected to reach at a CAGR of 8.5% during 2025-2034." U.S. Microneedling market Size, Status, and Forecast for the 2025-2034. In-depth research has been compiled to provide the most up-to-date information on key aspects of the worldwide market. This research report covers major aspects of the U.S. Microneedling Market including drivers, restraints, historical and current trends, regulatory scenarios, and technological advancements. It provides the industry
Dermabrasion and Microneedling Market to Witness Huge Growth by Key Players: Med …
The market report delivers an all-inclusive analysis of the market structure along with a forecast of the various segments and sub-segments of the Dermabrasion and Microneedling industry. This wide-ranging market research report acts as a backbone for the success of business in any niche. The Dermabrasion and Microneedling market survey report has been prepared by conducting market research in a systematic manner. Moreover, the Dermabrasion and Microneedling report includes a
Investigation announced for Long-Term Investors in BELLUS Health Inc. (NASDAQ: B …
An investigation on behalf of current long-term investors in shares of BELLUS Health Inc. (NASDAQ: BLU) concerning potential breaches of fiduciary duties by certain directors and officers of BELLUS Health Inc. was announced. Investors who are current long term investors in BELLUS Health Inc. (NASDAQ: BLU) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for
Deadline on May 17th coming up in Lawsuit for Investors in BELLUS Health Inc. (N …
A deadline is coming up on May 17, 2021 in the lawsuit filed for certain investors of BELLUS Health Inc. (NASDAQ: BLU) over alleged securities laws violations by BELLUS Health Inc. Investors who purchased shares of BELLUS Health Inc. (NASDAQ: BLU) have certain options and there are strict and short deadlines running. Deadline: May 17, 2021. NASDAQ: BLU stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -
Lawsuit filed for Investors in shares of BELLUS Health Inc. (NASDAQ: BLU)
An investor, who purchased shares of BELLUS Health Inc. (NASDAQ: BLU), filed a lawsuit over alleged violations of Federal Securities Laws by BELLUS Health Inc. Investors who purchased shares of BELLUS Health Inc. (NASDAQ: BLU) have certain options and for certain investors are short and strict deadlines running. Deadline: May 17, 2021. NASDAQ: BLU investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. Canada based BELLUS Health
Sarcoidosis Drug Market : By Relief therapeutics holding SA, Firststring researc …
Sarcoidosis Drug Market Report examines the competitive scenario and gives all major players market share based on production capacity, sales, revenues, geographical presence and other important factors. The report includes a detailed description, a competitive scenario, a wide range of market leaders and business strategies adopted by competitors together with their SWOT analysis. It also provides explicit information about fusions, acquisitions, joint ventures and other important market activities in recent years.